Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Julphar
Chinese Patent Office
Fuji
Daiichi Sankyo
Harvard Business School
Queensland Health
Citi
Accenture
McKesson

Generated: January 18, 2018

DrugPatentWatch Database Preview

CLOBETASOL PROPIONATE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for clobetasol propionate and what is the scope of clobetasol propionate patent protection?

Clobetasol propionate
is the generic ingredient in ten branded drugs marketed by Ingenus Pharms Llc, Perrigo Israel, Mylan Pharms Inc, Fougera Pharms Inc, G And W Labs Inc, Taro, Teva Pharms Usa, Fougera Pharms, Novast Labs Ltd, Teligent Pharma Inc, Hi Tech Pharma, Perrigo Co, Actavis Mid Atlantic, Lupin Ltd, Galderma Labs Lp, Glenmark Pharms, Zydus Pharms Usa Inc, Hi-tech Pharmacal, Galderma Labs, Macleods Pharms Ltd, Novel Labs Inc, Tolmar, Wockhardt, Akorn, and Paddock Llc, and is included in fifty-six NDAs. There are eleven patents protecting this compound and four Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Clobetasol propionate has one hundred and seven patent family members in twenty-six countries.

There are thirteen drug master file entries for clobetasol propionate. Thirty-six suppliers are listed for this compound. There is one tentative approval for this compound.
Summary for CLOBETASOL PROPIONATE
Pharmacology for CLOBETASOL PROPIONATE
Medical Subject Heading (MeSH) Categories for CLOBETASOL PROPIONATE
Tentative approvals for CLOBETASOL PROPIONATE
Applicant Application No. Strength Dosage Form
➤ Subscribe➤ Subscribe0.05%SPRAY;TOPICAL

US Patents and Regulatory Information for CLOBETASOL PROPIONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms CLOBETASOL PROPIONATE clobetasol propionate OINTMENT;TOPICAL 074407-001 Feb 23, 1996 AB RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fougera Pharms TEMOVATE clobetasol propionate GEL;TOPICAL 020337-001 Apr 29, 1994 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hi-tech Pharmacal CLOBETASOL PROPIONATE clobetasol propionate SHAMPOO;TOPICAL 209871-001 Oct 27, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Perrigo Israel CLOBETASOL PROPIONATE clobetasol propionate SHAMPOO;TOPICAL 090974-001 Aug 9, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Macleods Pharms Ltd CLOBETASOL PROPIONATE clobetasol propionate SOLUTION;TOPICAL 209361-001 Oct 25, 2017 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Galderma Labs CLOBEX clobetasol propionate SHAMPOO;TOPICAL 021644-001 Feb 5, 2004 AB RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Fougera Pharms TEMOVATE clobetasol propionate SOLUTION;TOPICAL 019966-001 Feb 22, 1990 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Taro CLOBETASOL PROPIONATE clobetasol propionate GEL;TOPICAL 075279-001 May 28, 1999 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teligent Pharma Inc CLOBETASOL PROPIONATE clobetasol propionate GEL;TOPICAL 208881-001 Mar 6, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Pharms Usa CLOBETASOL PROPIONATE clobetasol propionate CREAM;TOPICAL 074087-001 Feb 16, 1994 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for CLOBETASOL PROPIONATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Fougera Pharms TEMOVATE clobetasol propionate SOLUTION;TOPICAL 019966-001 Feb 22, 1990 ➤ Subscribe ➤ Subscribe
Mylan Pharms Inc OLUX clobetasol propionate AEROSOL, FOAM;TOPICAL 021142-001 May 26, 2000 ➤ Subscribe ➤ Subscribe
Fougera Pharms TEMOVATE clobetasol propionate CREAM;TOPICAL 019322-001 Dec 27, 1985 ➤ Subscribe ➤ Subscribe
Fougera Pharms TEMOVATE clobetasol propionate OINTMENT;TOPICAL 019323-001 Dec 27, 1985 ➤ Subscribe ➤ Subscribe
Galderma Labs Lp CLOBEX clobetasol propionate LOTION;TOPICAL 021535-001 Jul 24, 2003 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for CLOBETASOL PROPIONATE

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
5,886,038 Composition and method for treatment of psoriasis ➤ Subscribe
8,263,580 Vitamin formulation ➤ Subscribe
9,492,384 Microemulsion and sub-micron emulsion process and compositions ➤ Subscribe
8,298,515 Vitamin formulation ➤ Subscribe
8,629,128 Vitamin formulation ➤ Subscribe
8,449,867 Microemulsion and sub-micron emulsion process and compositions ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for CLOBETASOL PROPIONATE

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Argus Health
Novartis
Dow
Deloitte
Covington
Mallinckrodt
Cerilliant
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot